Search results
Manning, Brand Velocity Group eye minority NFL team stake amid potential private equity rule change
Sports Business Journal· 10 hours agoFormer NFLer Eli Manning’s Brand Velocity Group is hoping to take advantage of potential NFL rules changes that would allow private equity firms to own minority stakes of franchises.
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 2 hours agoStructure Therapeutics is an overlooked player in the GLP-1 market, and could one day boast a...
Analyzing Lilly(Eli) & Co
Knox Daily· 10 hours agoLilly(Eli) & Co’s recently made public that its SVP, Finance, & CAO Zakrowski Donald A unloaded Company’s shares for reported $0.57 million on Mar 11 ’24. In the deal valued ...
China clears Eli Lilly’s weight-loss drug, only for diabetes now - Indianapolis Business Journal
Indianapolis Business Journal· 10 hours agoChina gave the greenlight to Eli Lilly and Co.’s blockbuster drug tirzepatide for use in treating...
‘The Smashing Machine’ First Look: Dwayne Johnson Transforms Into MMA Icon Mark Kerr in Benny...
Variety· 4 hours agoThe film casts Johnson as legendary MMA fighter Mark Kerr, who struggled with addiction and his...
Television Analyst Blames Fake Mossad Agent ‘Eli Copter’ for Iranian President’s Death in Live...
The New York Sun· 21 hours agoA television journalist is being mocked online for falling for a prank by naming the killer of...
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
Zacks via Yahoo Finance· 1 day agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Aktis to collaborate with Eli Lilly on cancer therapies
WHTC 1450 Holland· 5 hours ago(Reuters) - Aktis Oncology said on Tuesday it will collaborate with Eli Lilly to develop cancer...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 5 hours agoThose remain in early to mid-stage development, however, and will have to prove competitive to Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. Further...
Eli Lilly stock maintains price target with Jefferies' buy rating By Investing.com
Investing.com· 1 day agoOn Monday, Jefferies maintained a confident stance on Eli Lilly (NYSE:LLY) shares, reiterating a Buy rating and a price target of $915.00. The affirmation comes after competitor ...
